HIT Consultant November 21, 2025
Fred Pennic

What You Should Know:

– The U.S. Food and Drug Administration (FDA) has recently issued several key clearances, marking significant advancements across diagnostics, surgery, and remote patient monitoring.

– These FDA clearances reflect a deepening integration of Artificial Intelligence (AI) and advanced technology into clinical workflows, promising greater precision, reduced invasiveness, and expanded access to care.

Diagnostics and Remote Monitoring: AI and Wearables at Scale

A major trend in recent clearances focuses on leveraging AI and comfortable wearables to enhance diagnostic speed and continuity of care.

Wearable Cardiopulmonary Monitoring

Hexoskin Receives 510(k) Clearance for Long-Term ECG and Respiratory Monitoring

Carré Technologies Inc. (dba Hexoskin) received 510(k) clearance for its Hexoskin Medical System (HMS) for continuous long-term ECG, respiratory monitoring, and...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Digital Health, FDA, Govt Agencies, Technology
The Medical Futurist’s 100 Digital Health And AI Companies Of 2026
The $20B Opportunity: Transforming Unused Health Data into a Strategic Asset
Canada: Acute Care EHR & Digital Health 2026-What's Changing Now in Adoption, Implementation, Selection and Satisfaction - Black Book Research
Digital Health Solutions at CES 2026
Two App Updates Make The Apple Watch Even Better For Fitness Tracking

Share Article